HOT TOPICS

HIV-Associated Cardiovascular Disease

• Vascular disease in HIV-infected patients
• Metabolic syndrome, dyslipidemia and myocardial ischemia/infarction in AIDS
• Cardiac mitochrondrial disease in AIDS
• Antiretroviral cardiac disease in children

Low HDL Cholesterol

• What is the risk associated with low HDL cholesterol?
• From genomics to proteomics: Unraveling HDL heterogeneity
• Novel strategies to raise HDL levels

Hypertension and Heart Failure

• Epidemiology, pathophysiology
• Hypertension and systolic heart failure
• The link between hypertension and heart failure with preserved ejection fraction

More Highlights

• Phospholipase and cardiovascular disease: How do we measure inflammation and what is its role in plaque rupture?
• Atherosclerosis update: How to identify and treat high-risk patients
• Left ventricular hypertrophy: Risks and causes

Learn from the Experts

• Weight loss in ischemic heart disease: What is the best approach?
• Statin myopathy: Causes, diagnosis, and treatment of this vexing problem
• Managing risk factors without medications
• What is the role of diuretics and beta blockers in treating hypertension?

VHP Spotlight

• Are the benefits of statins based only on LDL reduction?
• HDL-raising therapies: Can the promise be fulfilled?
• State-of-the-Art lecture: Role of exercise in the treatment of metabolic syndrome
• Should beta blockers be initial antihypertensive therapy?
• Should antihypertensive therapy target a reduction in LV mass?
• Renal artery hypertension and the role of renal stenting
• The role of salt in hypertension

PLUS
With Full-Access registration, i2 Summit also offers:

• Imaging of vulnerable plaque
• The latest in endovascular evaluation and treatment
• Percutaneous approaches to aortic disease
• Interactive case presentations and discussions throughout the day on clinical strategies of importance to both interventional and general cardiologists